Skip to main content

Table 1 Correlations between PXN expression and clinicopathological characteristics in gastric cancer patients

From: Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer

  

PXN expression

 

Characteristics

Total No.

Low No. cases (%)

High No. cases (%)

P value

Age

   

0.742

 < 60

116

75(49.3)

41(47.1)

 

 ≥ 60

123

77(50.7)

46(52.9)

 

Gender

   

0.096

 Male

177

118(77.6)

59(67.8)

 

 Female

62

34(22.4)

28(32.2)

 

Tumor depth

   

0.527

 T1

11

9(5.9)

2(2.3)

 

 T2

29

20(13.2)

9(10.3)

 

 T3

176

109(71.7)

67(77.0)

 

 T4

23

14(9.2)

9(10.4)

 

Lymph node invasion

   

0.656

 N0

55

35(23.0)

20(22.9)

 

 N1

85

58(38.2)

27(31.0)

 

 N2

64

39(25.6)

25(28.7)

 

 N3

35

20(13.2)

15(17.4)

 

Distant metastasis

   

0.001a

 M0

173

121(79.6)

52(59.7)

 

 M1

66

31(20.4)

35(40.3)

 

Differentiation status

   

0.388

 Well

99

68(44.7)

31(35.6)

 

 Moderate

92

55(36.1)

37(42.5)

 

 Poor and others

48

29(19.2)

19(21.9)

 

TNMb stage

   

0.021a

 I

28

20(13.1)

8(9.1)

 

 II

37

23(15.1)

14(16.1)

 

 III

100

72(47.3)

28(32.2)

 

 IV

74

37(24.5)

37(42.6)

 

Treatment

   

0.386

 Surgery only

116

77(50.7)

39(44.8)

 

 Surgery + chemotherapy

123

75(49.3)

48(55.2)

 

Survival status

   

0.004a

 Alive

98

73(48.0)

25(28.7)

 

 Dead

141

79(52.0)

62(71.3)

 
  1. aP < 0.05, Chi-square test; bTNM: T, tumor; N, lymph node; M, distant metastasis.